BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28804820)

  • 1. Performance and Interpretation of Mixing Tests in Coagulation.
    Kershaw G
    Methods Mol Biol; 2017; 1646():85-90. PubMed ID: 28804820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
    Kershaw G; Orellana D
    Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
    Chen J; Phillips B; Chandler WL
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants.
    Kershaw G
    Methods Mol Biol; 2017; 1646():75-83. PubMed ID: 28804819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin time and partial thromboplastin time assay considerations.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
    Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
    Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.
    Li R; Swaelens C; Vandermijnsbrugge F; Cantinieaux B
    Eur J Haematol; 2016 Jun; 96(6):578-85. PubMed ID: 26179977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and Measurement of Factor Inhibitors.
    Kershaw G
    Methods Mol Biol; 2017; 1646():295-304. PubMed ID: 28804837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Test for detection of activated partial thromboplastin time using ellagic acid].
    Berkovskiĭ AL; Sergeeva EV; Kachalova ND; Prostakova TM; Kozlov AA
    Klin Lab Diagn; 1999 Jun; (6):18-20. PubMed ID: 10459199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
    Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
    Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to interpret a prolonged prothrombin time or activated partial thromboplastin time.
    Desborough MJ; Keeling DM
    Br J Hosp Med (Lond); 2013 Jan; 74(1):C10-2. PubMed ID: 23593673
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significantly Prolonged Prothrombin Time and Activated Partial Thromboplastin Time with no Bleeding Tendency: A Patient with Lupus Anticoagulant-Hypoprothrombinemia Syndrome Positive for Immunoglobulin M Anti-Phosphatidylserine/Prothrombin complex Antibodies.
    Fei Y; Tang N; Zhang H; Li G; Zhang H; Zhang C
    Semin Thromb Hemost; 2020 Jun; 46(4):507-511. PubMed ID: 31877567
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency.
    Corno AR; Campolo J; Redaelli R; Caimi TM; Mostarda G; Morra E; Nichelatti M
    Thromb Res; 2010 Aug; 126(2):e152-3. PubMed ID: 20207395
    [No Abstract]   [Full Text] [Related]  

  • 17. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global coagulation assays: a clinical perspective.
    Zia A; O'Brien SH
    J Thromb Thrombolysis; 2015 Jan; 39(1):89-94. PubMed ID: 25244973
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Komiyama Y
    Thromb Res; 2016 Jul; 143():53-7. PubMed ID: 27182981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.